Menu
GeneBe

rs62636605

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_006950.3(SYN1):c.912C>T(p.Ala304=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0026 in 1,210,006 control chromosomes in the GnomAD database, including 60 homozygotes. There are 838 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 23 hom., 393 hem., cov: 23)
Exomes 𝑓: 0.0015 ( 37 hom. 445 hem. )

Consequence

SYN1
NM_006950.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.82
Variant links:
Genes affected
SYN1 (HGNC:11494): (synapsin I) This gene is a member of the synapsin gene family. Synapsins encode neuronal phosphoproteins which associate with the cytoplasmic surface of synaptic vesicles. Family members are characterized by common protein domains, and they are implicated in synaptogenesis and the modulation of neurotransmitter release, suggesting a potential role in several neuropsychiatric diseases. This member of the synapsin family plays a role in regulation of axonogenesis and synaptogenesis. The protein encoded serves as a substrate for several different protein kinases and phosphorylation may function in the regulation of this protein in the nerve terminal. Mutations in this gene may be associated with X-linked disorders with primary neuronal degeneration such as Rett syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant X-47576566-G-A is Benign according to our data. Variant chrX-47576566-G-A is described in ClinVar as [Benign]. Clinvar id is 130386.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.82 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0133 (1487/111775) while in subpopulation AFR AF= 0.0458 (1406/30684). AF 95% confidence interval is 0.0438. There are 23 homozygotes in gnomad4. There are 393 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 23 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SYN1NM_006950.3 linkuse as main transcriptc.912C>T p.Ala304= synonymous_variant 7/13 ENST00000295987.13
SYN1NM_133499.2 linkuse as main transcriptc.912C>T p.Ala304= synonymous_variant 7/13

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SYN1ENST00000295987.13 linkuse as main transcriptc.912C>T p.Ala304= synonymous_variant 7/132 NM_006950.3 P3P17600-1
SYN1ENST00000340666.5 linkuse as main transcriptc.912C>T p.Ala304= synonymous_variant 7/131 A1P17600-2

Frequencies

GnomAD3 genomes
AF:
0.0132
AC:
1479
AN:
111720
Hom.:
23
Cov.:
23
AF XY:
0.0114
AC XY:
386
AN XY:
33884
show subpopulations
Gnomad AFR
AF:
0.0456
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00549
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000742
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00840
Gnomad NFE
AF:
0.0000752
Gnomad OTH
AF:
0.0106
GnomAD3 exomes
AF:
0.00386
AC:
709
AN:
183492
Hom.:
13
AF XY:
0.00244
AC XY:
166
AN XY:
67920
show subpopulations
Gnomad AFR exome
AF:
0.0456
Gnomad AMR exome
AF:
0.00310
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000262
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000732
Gnomad OTH exome
AF:
0.00287
GnomAD4 exome
AF:
0.00151
AC:
1659
AN:
1098231
Hom.:
37
Cov.:
33
AF XY:
0.00122
AC XY:
445
AN XY:
363585
show subpopulations
Gnomad4 AFR exome
AF:
0.0462
Gnomad4 AMR exome
AF:
0.00352
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000388
Gnomad4 FIN exome
AF:
0.0000493
Gnomad4 NFE exome
AF:
0.0000594
Gnomad4 OTH exome
AF:
0.00499
GnomAD4 genome
AF:
0.0133
AC:
1487
AN:
111775
Hom.:
23
Cov.:
23
AF XY:
0.0116
AC XY:
393
AN XY:
33949
show subpopulations
Gnomad4 AFR
AF:
0.0458
Gnomad4 AMR
AF:
0.00548
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000372
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000752
Gnomad4 OTH
AF:
0.0105
Alfa
AF:
0.00617
Hom.:
22
Bravo
AF:
0.0160
EpiCase
AF:
0.000109
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxAug 06, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsSep 30, 2017- -
Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
History of neurodevelopmental disorder Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsApr 13, 2016This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
Cadd
Benign
0.41
Dann
Benign
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs62636605; hg19: chrX-47435965; API